US Stock MarketDetailed Quotes

IOBT IO Biotech

Watchlist
  • 1.530
  • -0.020-1.29%
Close May 2 16:00 ET
100.80MMarket Cap-772P/E (TTM)

About IO Biotech Company

IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms. The company was founded by Mai-Britt Zocca, Inge Marie Svane, and Mads Hald Andersen in December 2014 and is headquartered in Copenhagen, Denmark.

Company Profile

SymbolIOBT
Company NameIO Biotech
Listing DateNov 5, 2021
Issue Price14.00
Founded2014
CEODr. Mai-Britt Zocca, PhD
MarketNASDAQ
Employees68
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressOle Maal?es Vej 3
CityCopenhagen
ProvinceNorth Denmark
CountryDenmark
Zip Code2200
Phone45-70-70-29-80
Websitehttp://www.iobiotech.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Mai-Britt Zocca, PhD
  • Chief Executive Officer, President and Director
  • 1.65M
  • Dr. Qasim Ahmad, M.D.
  • Chief Medical Officer
  • 920.76K
  • Amy Sullivan, M.B.A.
  • Chief Financial Officer
  • --
  • Dr. Peter Hirth, PhD
  • Chairman of the Board
  • 145.75K
  • Dr. Helen Collins, M.D.
  • Independent Director
  • 52.48K
  • David V. Smith, M.B.A.
  • Independent Director
  • 124.17K
  • Dr. Christian Elling, PhD
  • Independent Director
  • 114.14K
  • Heidi Hunter
  • Independent Director
  • 112.61K
  • Kathleen Sereda Glaub, M.B.A.
  • Independent Director
  • 133.00K
  • Devin Whittemore Smith
  • General Counsel
  • 917.30K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg